HomeCompareBASX vs PFE

BASX vs PFE: Dividend Comparison 2026

BASX yields 3333.33% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BASX wins by $1244041712890.35M in total portfolio value
10 years
BASX
BASX
● Live price
3333.33%
Share price
$0.06
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1244041712890.40M
Annual income
$1,174,716,366,071,938,000.00
Full BASX calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — BASX vs PFE

📍 BASX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBASXPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BASX + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BASX pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BASX
Annual income on $10K today (after 15% tax)
$283,333.33/yr
After 10yr DRIP, annual income (after tax)
$998,508,911,161,147,300.00/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, BASX beats the other by $998,508,911,161,125,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BASX + PFE for your $10,000?

BASX: 50%PFE: 50%
100% PFE50/50100% BASX
Portfolio after 10yr
$622020856445.22M
Annual income
$587,358,183,035,982,200.00/yr
Blended yield
94.43%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

BASX
Analyst Ratings
1
Buy
3
Hold
Consensus: Hold
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BASX buys
0
PFE buys
0
No recent congressional trades found for BASX or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBASXPFE
Forward yield3333.33%6.13%
Annual dividend / share$2.00$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%13.2%
Portfolio after 10y$1244041712890.40M$49.6K
Annual income after 10y$1,174,716,366,071,938,000.00$26,258.71
Total dividends collected$1239274250481.68M$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldHold

Year-by-year: BASX vs PFE ($10,000, DRIP)

YearBASX PortfolioBASX Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$344,033$333,333.33$9,153$693.39+$334.9KBASX
2$11,085,665$10,717,549.33$8,593$849.25+$11.08MBASX
3$334,616,633$322,754,971.08$8,336$1,066.78+$334.61MBASX
4$9,462,934,690$9,104,894,892.71$8,437$1,384.80+$9462.93MBASX
5$250,766,259,005$240,640,918,887.41$9,013$1,875.40+$250766.25MBASX
6$6,228,082,462,189$5,959,762,565,053.11$10,306$2,680.72+$6228082.45MBASX
7$144,998,525,500,125$138,334,477,265,582.72$12,820$4,101.38+$144998525.49MBASX
8$3,165,074,899,913,431$3,009,926,477,628,297.00$17,673$6,826.70+$3165074899.90MBASX
9$64,790,043,755,570,470$61,403,413,612,663,110.00$27,543$12,591.86+$64790043755.54MBASX
10$1,244,041,712,890,398,500$1,174,716,366,071,938,000.00$49,560$26,258.71+$1244041712890.35MBASX

BASX vs PFE: Complete Analysis 2026

BASXStock

Basic Energy Services, Inc. provides wellsite services to oil and natural gas drilling and producing companies in the United States. Its Well Servicing segment provides services performed with a mobile well servicing rig and ancillary equipment, such as maintenance work involving removal, repair, and replacement of down-hole equipment; hoisting tools and equipment required by the operation into and out of the well, or removing equipment from the well bore; and plugging and abandonment services, as well as manufactures and sells workover rigs. As of December 31, 2019, this segment operated a fleet of 306 well servicing rigs. The company's Water Logistics segment provides oilfield fluid supply, transportation, storage, and midstream services, such as the operation of company-owned fresh water and brine source wells and of non-hazardous wastewater disposal wells; sale and transportation of fresh and brine water; transportation of fluids used in drilling, completion, workover, and flowback operations and of saltwater produced as a by-product; rental of portable fracturing tanks and test tanks; recycling and treatment of wastewater, including produced water and flowback; and preparation, construction, and maintenance of access roads, drilling locations, and production facilities. This segment owned and operated 762 fluid service trucks with an average fluid hauling capacity of up to 150 barrels; and owned 87 saltwater disposal wells. Its Completion & Remedial Services segment offers services, including rental and fishing tools; coiled tubing; snubbing services; thru-tubing; and underbalanced drilling in low pressure and fluid sensitive reservoirs. This segment operates 24 air compressor packages, 32 snubbing units, and 9 coiled tubing units. The company was formerly known as Sierra Well Service, Inc. and changed its name to Basic Energy Services, Inc. in 2000. Basic Energy Services, Inc. was founded in 1992 and is headquartered in Fort Worth, Texas.

Full BASX Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this BASX vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BASX vs SCHDBASX vs JEPIBASX vs OBASX vs KOBASX vs MAINBASX vs JNJBASX vs MRKBASX vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.